TYBR Health Lands $30M Series A for Surgical Hydrogel

July 26, 2026

Fundraise Insider tracks newly funded startups each week and delivers verified B2B leads list of C-suite contacts straight to your inbox, so you reach the right people while the funding is still fresh. See pricing.

TYBR Health, a medical device company based in Houston, Texas, has raised a $30 million Series A to widen access to its B3 GEL System. Vensana Capital and Mutual Capital Partners led the round, which the company announced on July 21, 2026.

Neovate Capital Partners joined the financing, along with existing investors. TYBR develops products meant to improve healing and recovery after surgery, built on an extracellular matrix technology platform designed to give surgeons practical tools for protecting healing tissue.

The B3 GEL System, which is cleared by the FDA, reached the US market in January 2026. The company plans to put the new capital mainly toward expanding commercial access to the hydrogel, broadening the product’s indications, and running clinical studies that evaluate tissue protection during orthopedic surgery.

You may also like

35 Sales Email Tips to Crush Your Sales Game

In today’s digital age, email remains one of the most effective tools for reaching out to potential customers and driving sales. However, crafting a successful sales email can be tricky, as you need […]

Recently Funded Startups Are A Great Sales Target. Here’s Why.

The startup industry has been growing at an unprecedented rate in recent years, with billions of dollars being poured into the sector every year. This growth has created an opportunity for businesses to […]

How to Identify Your B2B Target Audience: A Comprehensive Guide

For any business to succeed, it is essential to target the right audience. In B2B marketing, identifying your target audience is even more important, as it helps you focus your efforts and resources […]